Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Consolidated Net Income (2021 - 2025)

Historic Consolidated Net Income for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to $7.4 million.

  • Arcutis Biotherapeutics' Consolidated Net Income rose 11783.95% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.3 million, marking a year-over-year increase of 7733.19%. This contributed to the annual value of -$140.0 million for FY2024, which is 4657.85% up from last year.
  • Arcutis Biotherapeutics' Consolidated Net Income amounted to $7.4 million in Q3 2025, which was up 11783.95% from -$15.9 million recorded in Q2 2025.
  • Arcutis Biotherapeutics' Consolidated Net Income's 5-year high stood at $7.4 million during Q3 2025, with a 5-year trough of -$107.7 million in Q3 2022.
  • Moreover, its 5-year median value for Consolidated Net Income was -$52.3 million (2024), whereas its average is -$50.2 million.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Consolidated Net Income plummeted by 8870.49% in 2022, and later surged by 11783.95% in 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Consolidated Net Income (Quarter) stood at -$71.3 million in 2021, then dropped by 1.03% to -$72.0 million in 2022, then grew by 7.96% to -$66.3 million in 2023, then soared by 83.72% to -$10.8 million in 2024, then surged by 168.69% to $7.4 million in 2025.
  • Its Consolidated Net Income was $7.4 million in Q3 2025, compared to -$15.9 million in Q2 2025 and -$25.1 million in Q1 2025.